ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Preclinical

KPV

KPV

Also known as: KPV Tripeptide, Alpha-MSH Fragment 11-13

Overview

Key Facts

Primary Goal: A tripeptide fragment from the C-terminus of alpha-melanocyte stimulating hormone (alpha-MSH)

A tripeptide fragment from the C-terminus of alpha-melanocyte stimulating hormone (alpha-MSH). Possesses potent anti-inflammatory and antimicrobial properties without melanogenic effects. Particularly relevant for immune regulation in gut and mucosal tissues. Half-Life ~30 minutes Typical Dose 200–500 mcg Frequency 1-2x daily Cycle Length 4-12 weeks

Dosing Information

Half-Life

~30 minutes

Typical Dose

200–500 mcg

Frequency

1-2x daily

Cycle Length

4-12 weeks

Administration Routes:

subcutaneousoraltopical

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F) or -20°C (-4°F) for long-term
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2 weeks

Research Summary

Preclinical

Studied in preclinical models of inflammatory bowel disease, colitis, and skin inflammation. Demonstrated efficacy comparable to standard anti-inflammatory treatments in murine IBD models. Strong in vitro evidence for NF-kB inhibition. Cross-reference: see kpv in healing-recovery for tissue repair context.

Frequently Asked Questions

Common questions about KPV

UK-Specific Information

Exclusive data points and guidance for UK residents using KPV

UK Lab Testing

US Lab Testing

Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With